my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.
Source link : http://pink.citeline.com/PS147563/Blow-For-Pfizer-As-UKs-NICE-Rejects-Oxbryta-For-Sickle-Cell-Disease
Author :
Publish date : 2023-09-17 20:19:49
Copyright for syndicated content belongs to the linked Source.